LRIG3 and central nervous system cancer: We revealed for the first time a negative association between LRIG3/sLRIG3 and MET signaling in human glioblastoma and provided compelling evidence in support of the hypothesis that LRIG3 and sLRIG3 could serve as tumor suppressors in human gliomas.